XML 65 R50.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Development Liability - Additional Information (Detail) $ in Thousands |  | 1 Months Ended | 8 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | ---
Feb. 28, 2019 USD ($) Installment | Dec. 31, 2023 USD ($) | May 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | May 31, 2022 USD ($) | Jan. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) Installment | Dec. 31, 2021 USD ($) | Jun. 30, 2021 USD ($) | Jan. 31, 2020 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Jun. 30, 2019 USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  |  |  |  |  |  |  |  |  | $ 29,581 | $ 32,626 | $ 13,241 |
SFJ Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from SFJ agreement | $ 60,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Additional funding amount upon achievement of development milestones | $ 60,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of milestone payments | Installment | 3 |  |  |  |  |  |  |  |  |  |  |  |  |
Development funding for minimum period of operating expense | 10 months |  |  |  |  |  |  |  |  |  |  |  |  |
Increase in additional funding for development costs |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 20,000
Obligated to pay initial payment |  | $ 366,000 |  |  |  |  | $ 5,000 | $ 5,000 |  |  | 366,000 |  | 5,000 |
Aggregate amount of additional annual payments |  |  |  |  |  |  | $ 225,000 | 225,000 |  |  |  |  | $ 225,000 |
Number of additional annual payments | Installment |  |  |  |  |  |  | 6 |  |  |  |  |  |  |
Payment made under agreement |  |  |  |  |  | $ 5,000 |  |  | $ 4,000 | $ 80,000 | 94,000 |  |  |
First annual payment under agreement |  |  |  | $ 18,000 | $ 11,500 |  |  |  |  |  |  |  |  |
Second annual payment under agreement |  | $ 31,000 | $ 24,500 |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  |  |  |  |  |  | $ 1,200 |  |  | $ 26,000 | $ 26,900 |  |
SFJ Agreement [Member] | Regulatory Approval Granted US Food and Drug Administration [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Obligated to pay initial payment | $ 4,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate amount of additional annual payments | $ 226,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of additional annual payments | Installment | 6 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Additional funding amount upon achievement of development milestones. + References No definition available. + Details
Name: | apls_AdditionalFundingAmountUponAchievementOfDevelopmentMilestones
Namespace Prefix: | apls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate amount of additional annual payments. + References No definition available. + Details
Name: | apls_AggregateAmountOfAdditionalAnnualPayments
Namespace Prefix: | apls_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Development funding for minimum period of operating expense + References No definition available. + Details
Name: | apls_DevelopmentFundingForMinimumPeriodOfOperatingExpense
Namespace Prefix: | apls_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition First annual payment under agreement. + References No definition available. + Details
Name: | apls_FirstAnnualPaymentUnderAgreement
Namespace Prefix: | apls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase in additional funding for development costs. + References No definition available. + Details
Name: | apls_IncreaseInAdditionalFundingForDevelopmentCosts
Namespace Prefix: | apls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Interest expense nonoperating. + References No definition available. + Details
Name: | apls_InterestExpenseNonoperating
Namespace Prefix: | apls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of additional annual payments. + References No definition available. + Details
Name: | apls_NumberOfAdditionalAnnualPayments
Namespace Prefix: | apls_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of milestone payments. + References No definition available. + Details
Name: | apls_NumberOfMilestonePayments
Namespace Prefix: | apls_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Payment made under agreement. + References No definition available. + Details
Name: | apls_PaymentMadeUnderAgreement
Namespace Prefix: | apls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Second annual payment under agreement. + References No definition available. + Details
Name: | apls_SecondAnnualPaymentUnderAgreement
Namespace Prefix: | apls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Cash received from collaborators during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_ProceedsFromCollaborators
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=apls_SFJAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RegulatoryAgencyAxis=apls_FoodAndDrugAdministrationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |